Skip to main content
Erschienen in: Pediatric Nephrology 7/2006

01.07.2006 | Editorial Commentary

Unilateral renal ischemia causing the hyponatremic hypertensive syndrome in children—more common than we think?

verfasst von: M. Gary Nicholls

Erschienen in: Pediatric Nephrology | Ausgabe 7/2006

Einloggen, um Zugang zu erhalten

Abstract

A case report in the journal Pediatric Nephrology describes a 15-month-old girl with the syndrome of hypertension and hyponatremia (HH syndrome) due to underlying unilateral renal artery stenosis. This syndrome is typically associated with hypokalemia and severe volume depletion and sometimes proteinuria, all of which, along with hypertension and hyponatremia, are usually corrected by resolution of the underlying renal ischemia. Gross and probably sudden activation of the renin-angiotensin system in response to renal ischemia is central to the pathophysiology although the cardiac atrial and B-type natriuretic peptides probably contribute also. Initial control of the severe hypertension may, in some cases, require careful volume repletion prior to introduction of blockade of the renin–angiotensin system in order to avoid first-dose hypotension, after which correction of the underlying renal ischemia is required. Whereas the syndrome has rarely been reported in children, it is possible that, as in adults, this reflects its lack of recognition by clinicians. The HH syndrome due to unilateral renal ischemia in children may be much more common than we think.
Literatur
2.
Zurück zum Zitat Brown JJ, Davies DL, Lever AF, Robertson JIS (1965) Plasma renin concentration in human hypertension. 1: relationship between renin, sodium, and potassium. BMJ 2:144–148CrossRef Brown JJ, Davies DL, Lever AF, Robertson JIS (1965) Plasma renin concentration in human hypertension. 1: relationship between renin, sodium, and potassium. BMJ 2:144–148CrossRef
3.
Zurück zum Zitat Hilden T (1950) Hypertensive encephalopathy associated with hypochloremia. Acta Med Scand 76:199–202 Hilden T (1950) Hypertensive encephalopathy associated with hypochloremia. Acta Med Scand 76:199–202
4.
Zurück zum Zitat Holten C, Peterson VP (1956) Malignant hypertension with increased secretion of aldosterone and depletion of potassium. Lancet 2:918–922CrossRef Holten C, Peterson VP (1956) Malignant hypertension with increased secretion of aldosterone and depletion of potassium. Lancet 2:918–922CrossRef
5.
Zurück zum Zitat Bauer H, Forbes GL (1952) Unilateral renal artery obstruction associated with malignant nephrosclerosis confined to the opposite kidney. Am Heart J 44:634–638CrossRef Bauer H, Forbes GL (1952) Unilateral renal artery obstruction associated with malignant nephrosclerosis confined to the opposite kidney. Am Heart J 44:634–638CrossRef
6.
Zurück zum Zitat Agarwal M, Lynn KL, Richards AM, Nicholls MG (1999) Hyponatremic–hypertensive syndrome with renal ischemia. An underrecognized disorder. Hypertension 33:1020–1024CrossRef Agarwal M, Lynn KL, Richards AM, Nicholls MG (1999) Hyponatremic–hypertensive syndrome with renal ischemia. An underrecognized disorder. Hypertension 33:1020–1024CrossRef
7.
Zurück zum Zitat Leumann EP, Bauer RP, Slaton PE, Biglieri EG, Holliday MA (1970) Renovascular hypertension in children. Pediatrics 46:362–370PubMed Leumann EP, Bauer RP, Slaton PE, Biglieri EG, Holliday MA (1970) Renovascular hypertension in children. Pediatrics 46:362–370PubMed
8.
Zurück zum Zitat Rosendahl W, Ranke M, Mentzel H (1980) Sodium loss as leading symptom of renovascular hypertension in the newborn. Klin Wochenschr 58:953–954CrossRef Rosendahl W, Ranke M, Mentzel H (1980) Sodium loss as leading symptom of renovascular hypertension in the newborn. Klin Wochenschr 58:953–954CrossRef
9.
Zurück zum Zitat Fischbach H, Riemenschneider T, Mentzel H (1982) Morphologic aspects of Goldblatt hypertension in a newborn infant. Clin Nephrol 17:41–45PubMed Fischbach H, Riemenschneider T, Mentzel H (1982) Morphologic aspects of Goldblatt hypertension in a newborn infant. Clin Nephrol 17:41–45PubMed
10.
Zurück zum Zitat Blanc F, Bensman A, Baudon JJ (1991) Renovascular hypertension: a rare cause of neonatal salt loss. Pediatr Nephrol 5:304–306CrossRef Blanc F, Bensman A, Baudon JJ (1991) Renovascular hypertension: a rare cause of neonatal salt loss. Pediatr Nephrol 5:304–306CrossRef
11.
12.
Zurück zum Zitat Kaneko K, Shimazaki S, Ino T, Yabuta K, Nakazawa T, Takahashi H, Kaneko K (1994) Severe hyponatremia in a patient with renovascular hypertension: case report. Nephron 68:252–255CrossRef Kaneko K, Shimazaki S, Ino T, Yabuta K, Nakazawa T, Takahashi H, Kaneko K (1994) Severe hyponatremia in a patient with renovascular hypertension: case report. Nephron 68:252–255CrossRef
13.
Zurück zum Zitat Castello Girona F, Yeste Fernandez D, Porta Ribera R, Enriquez Civicos G (1996) Renovascular hypertension due to unilateral renal artery stenosis with hypokalemic alkalosis, the salt-losing syndrome and reversible hyperechogenicity of the contralateral kidney. A study of 2 infants. An Esp Pediatr 45:49–52PubMed Castello Girona F, Yeste Fernandez D, Porta Ribera R, Enriquez Civicos G (1996) Renovascular hypertension due to unilateral renal artery stenosis with hypokalemic alkalosis, the salt-losing syndrome and reversible hyperechogenicity of the contralateral kidney. A study of 2 infants. An Esp Pediatr 45:49–52PubMed
14.
Zurück zum Zitat Roux P, Harris S, Gilbert R, Burkimsherm D (1997) Renovascular hypertension and encephalopathy in a patient with tuberculous abdominal lymphadenopathy. Pediatrics 99:743–745CrossRef Roux P, Harris S, Gilbert R, Burkimsherm D (1997) Renovascular hypertension and encephalopathy in a patient with tuberculous abdominal lymphadenopathy. Pediatrics 99:743–745CrossRef
15.
Zurück zum Zitat Enriquez G, Castello F, Sousa P, Aso C, Lucaya J (1997) Increased cortical echogenicity of the normal kidney in infants with unilateral renal artery stenosis: report of two cases. J Ultrasound Med 16:59–63CrossRef Enriquez G, Castello F, Sousa P, Aso C, Lucaya J (1997) Increased cortical echogenicity of the normal kidney in infants with unilateral renal artery stenosis: report of two cases. J Ultrasound Med 16:59–63CrossRef
16.
Zurück zum Zitat Daftary AS, Patole SK, Whitehall J (1999) Hypertension–hyponatremia syndrome in neonates: case report and review of literature. Am J Perinatol 16:385–389CrossRef Daftary AS, Patole SK, Whitehall J (1999) Hypertension–hyponatremia syndrome in neonates: case report and review of literature. Am J Perinatol 16:385–389CrossRef
17.
Zurück zum Zitat Dahlem P, Groothoff JW, Aronson DC (2000) The hyponatraemic hypertensive syndrome in a 2-year-old child with behavioural symptoms. Eur J Pediatr 159:500–502CrossRef Dahlem P, Groothoff JW, Aronson DC (2000) The hyponatraemic hypertensive syndrome in a 2-year-old child with behavioural symptoms. Eur J Pediatr 159:500–502CrossRef
18.
Zurück zum Zitat Peco-Antic A, Krstic Z, Boric Z, Sagic D, Kostic M, Jovanovic O, Kruscic D, Spasojevic B, Paripovic D (2003) Renovascular hypertension in a child with type 1 neurofibromatosis. Srp Arh Celok Lek 131:254–258CrossRef Peco-Antic A, Krstic Z, Boric Z, Sagic D, Kostic M, Jovanovic O, Kruscic D, Spasojevic B, Paripovic D (2003) Renovascular hypertension in a child with type 1 neurofibromatosis. Srp Arh Celok Lek 131:254–258CrossRef
19.
Zurück zum Zitat Dixit MP, Hughes JD, Theodorou A, Dixit NM (2004) Hyponatremic hypertensive syndrome (HHS) in an 18-month old-child presenting as malignant hypertension: a case report. BMC Nephrol 5:5CrossRef Dixit MP, Hughes JD, Theodorou A, Dixit NM (2004) Hyponatremic hypertensive syndrome (HHS) in an 18-month old-child presenting as malignant hypertension: a case report. BMC Nephrol 5:5CrossRef
20.
Zurück zum Zitat Trivelli A, Ghiggeri GM, Canepa A, Oddone M, Bava G, Perfumo F (2005) Hyponatremic–hypertensive syndrome with extensive and reversible renal defects. Pediatr Nephrol 20:102–104CrossRef Trivelli A, Ghiggeri GM, Canepa A, Oddone M, Bava G, Perfumo F (2005) Hyponatremic–hypertensive syndrome with extensive and reversible renal defects. Pediatr Nephrol 20:102–104CrossRef
21.
Zurück zum Zitat Dustan HP, Tarazi RC, Frohlich ED (1970) Functional correlates of plasma renin activity in hypertensive patients. Circulation 41:555–567CrossRef Dustan HP, Tarazi RC, Frohlich ED (1970) Functional correlates of plasma renin activity in hypertensive patients. Circulation 41:555–567CrossRef
22.
Zurück zum Zitat McAreavey D, Brown JJ, Cumming AMM, Davies DL, Fraser R, Lever AF, Mackay A, Morton JJ, Robertson JIS (1983) Inverse relation of exchangeable sodium and blood pressure in hypertensive patients with renal artery stenosis. J Hypertens 1:297–302CrossRef McAreavey D, Brown JJ, Cumming AMM, Davies DL, Fraser R, Lever AF, Mackay A, Morton JJ, Robertson JIS (1983) Inverse relation of exchangeable sodium and blood pressure in hypertensive patients with renal artery stenosis. J Hypertens 1:297–302CrossRef
23.
Zurück zum Zitat Maslowski AH, Nicholls MG, Espiner EA, Ikram H, Bones PJ (1983) Mechanisms in human renovascular hypertension. Hypertension 5:597–602CrossRef Maslowski AH, Nicholls MG, Espiner EA, Ikram H, Bones PJ (1983) Mechanisms in human renovascular hypertension. Hypertension 5:597–602CrossRef
24.
Zurück zum Zitat Oelkers W, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JIS (1974) Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res 34:69–77CrossRef Oelkers W, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JIS (1974) Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res 34:69–77CrossRef
25.
Zurück zum Zitat Robertson JIS (1993) Renin and the nephrotic syndrome. In: Robertson JIS, Nicholls MG (eds) The renin–angiotensin system. Mosby, New York, pp 58.1–58.8 Robertson JIS (1993) Renin and the nephrotic syndrome. In: Robertson JIS, Nicholls MG (eds) The renin–angiotensin system. Mosby, New York, pp 58.1–58.8
26.
Zurück zum Zitat Larochelle P, Cusson JR, Gutkowska J, Schiffrin EL, Hamet P, Kuchel O, Genest J, Cantin M (1987) Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. BMJ 294:1249–1252CrossRef Larochelle P, Cusson JR, Gutkowska J, Schiffrin EL, Hamet P, Kuchel O, Genest J, Cantin M (1987) Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. BMJ 294:1249–1252CrossRef
27.
Zurück zum Zitat Mussalo H, Vanninen E, Ikaheimo R, Hartikainen J (2003) NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res 26:34–41CrossRef Mussalo H, Vanninen E, Ikaheimo R, Hartikainen J (2003) NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res 26:34–41CrossRef
28.
Zurück zum Zitat Silva JA, Chan AW, White CJ, Collins TJ, Jenkins JS, Reilly JP, Ramee SR (2005) Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 111:328–333CrossRef Silva JA, Chan AW, White CJ, Collins TJ, Jenkins JS, Reilly JP, Ramee SR (2005) Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 111:328–333CrossRef
29.
Zurück zum Zitat Suenaga K, Mizuno K, Niimura S, Mori K, Sato M, Tani M, Yabe R, Yatabe Y, Fukuchi S (1989) Atrial natriuretic factor (ANF) increases urinary protein excretion in patients with essential hypertension: a possible role of ANF for renal handling of protein. Biochem Biophys Res Commun 158:936–942CrossRef Suenaga K, Mizuno K, Niimura S, Mori K, Sato M, Tani M, Yabe R, Yatabe Y, Fukuchi S (1989) Atrial natriuretic factor (ANF) increases urinary protein excretion in patients with essential hypertension: a possible role of ANF for renal handling of protein. Biochem Biophys Res Commun 158:936–942CrossRef
30.
Zurück zum Zitat Richards AM, Nicholls MG, Espiner EA, Ikram H, Yandle TG, Joyce SL, Cullens MM (1985) Effects of alpha-human atrial natriuretic peptide in essential hypertension. Hypertension 7:812–817CrossRef Richards AM, Nicholls MG, Espiner EA, Ikram H, Yandle TG, Joyce SL, Cullens MM (1985) Effects of alpha-human atrial natriuretic peptide in essential hypertension. Hypertension 7:812–817CrossRef
31.
Zurück zum Zitat Trippodo NC, MacPhee AA, Cole FE (1984) Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. J Hypertens 2(Suppl 3):S289–S291 Trippodo NC, MacPhee AA, Cole FE (1984) Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. J Hypertens 2(Suppl 3):S289–S291
32.
Zurück zum Zitat Atkinson AB, Davies DL, Leckie B, Morton JJ, Brown JJ, Fraser R, Lever AF, Robertson JIS (1979) Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet 2:606–609CrossRef Atkinson AB, Davies DL, Leckie B, Morton JJ, Brown JJ, Fraser R, Lever AF, Robertson JIS (1979) Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet 2:606–609CrossRef
33.
Zurück zum Zitat Heslop H, Richards AM, Nicholls MG, Espiner EA, Ikram H, Maslowski AH (1985) Hyponatraemic–hypertensive syndrome due to unilateral renal ischaemia in women who smoke heavily. N Z Med J 98:739–742PubMed Heslop H, Richards AM, Nicholls MG, Espiner EA, Ikram H, Maslowski AH (1985) Hyponatraemic–hypertensive syndrome due to unilateral renal ischaemia in women who smoke heavily. N Z Med J 98:739–742PubMed
34.
Zurück zum Zitat Mohring J, Petri M, Szokol M, Haack D, Mohring B (1976) Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol 230:849–857CrossRef Mohring J, Petri M, Szokol M, Haack D, Mohring B (1976) Effects of saline drinking on malignant course of renal hypertension in rats. Am J Physiol 230:849–857CrossRef
35.
Zurück zum Zitat Kaneda H, Yamauchi T, Murata T, Matsumoto J, Haruyama T (1980) Treatment of malignant hypertension with infusion of sodium chloride; a case report and a review. Tohoku J Exp Med 132:179–186CrossRef Kaneda H, Yamauchi T, Murata T, Matsumoto J, Haruyama T (1980) Treatment of malignant hypertension with infusion of sodium chloride; a case report and a review. Tohoku J Exp Med 132:179–186CrossRef
36.
Zurück zum Zitat (1986) Hyponatraemic hypertensive syndrome. Lancet 1:718–719 (1986) Hyponatraemic hypertensive syndrome. Lancet 1:718–719
37.
Zurück zum Zitat Rosendahl W (1986) High pressure diuresis initiates malignant hypertension in the young. Clin Exp Hypertens 8:799–804 Rosendahl W (1986) High pressure diuresis initiates malignant hypertension in the young. Clin Exp Hypertens 8:799–804
38.
Zurück zum Zitat Dillon MJ (1997) The diagnosis of renovascular disease. Pediatr Nephrol 11:366–372CrossRef Dillon MJ (1997) The diagnosis of renovascular disease. Pediatr Nephrol 11:366–372CrossRef
39.
Zurück zum Zitat McTaggart SJ, Gelati S, Walker RG, Powell HR, Jones CL (2000) Evaluation and long-term outcome of pediatric renovascular hypertension. Pediatr Nephrol 14:1022–1029CrossRef McTaggart SJ, Gelati S, Walker RG, Powell HR, Jones CL (2000) Evaluation and long-term outcome of pediatric renovascular hypertension. Pediatr Nephrol 14:1022–1029CrossRef
Metadaten
Titel
Unilateral renal ischemia causing the hyponatremic hypertensive syndrome in children—more common than we think?
verfasst von
M. Gary Nicholls
Publikationsdatum
01.07.2006
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 7/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0107-5

Weitere Artikel der Ausgabe 7/2006

Pediatric Nephrology 7/2006 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.